Accessibility Menu

Epsilon Healthcare Ltd(ASX) THC

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-94%
5 Year-85%
1 Year+4%
1 Month+4%
N/A
Epsilon Healthcare Ltd last closing stock price
MetricPriceDate
Last closeAUD 0.032026-09-08
Epsilon Healthcare Ltd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.17%AUD 0.022026-09-01
1 month+4.17%AUD 0.022026-08-04
3 month+8.7%AUD 0.022026-06-10
Year to date-24.24%AUD 0.032025-12-31
1 year+4.17%AUD 0.022023-12-15
3 year+19.05%AUD 0.022023-09-07
5 year-84.85%AUD 0.172021-09-09
Since inception-93.58%AUD 0.412017-05-04

Epsilon Healthcare Ltd Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$4.26M

Net Income (TTM)

-A$11.06M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

THC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Epsilon Healthcare Ltd

Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company was founded on August 29, 2016 and is headquartered on Millers Point, Australia.

Industry

Pharmaceuticals

Sector

Health Care

CEO

Peter Giannopoulos

Website

www.epsilonhealthcare.com.au

THC Financials

Key Financial Metrics (TTM)

Gross Margin

36.17%

Operating Margin

-140.65%

Net Income Margin

-156.89%

Return on Equity

-48.28%

Return on Capital

-33.80%

Return on Assets

-31.34%

Earnings Yield

N/A

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

A$1.04M

Operating Income

-A$10.80M

EBITDA

-A$10.61M

Operating Cash Flow

A$0.00

Capital Expenditure

-A$1.29M

Free Cash Flow

-A$1.29M

Cash & ST Invst.

A$6.97M

Total Debt

A$5.11M

Epsilon Healthcare Ltd Performance Analysis

Epsilon Healthcare Ltd annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31AUD 4,651,801-15.4%
20232023-12-31AUD 6,651,52043.0%
20242024-12-31AUD 5,600,181-15.8%
20252025-12-31AUD 9,393,66067.7%
Epsilon Healthcare Ltd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12019-03-31N/A
Q22019-06-30N/A
Q42019-12-31N/A
Q42020-12-31N/A
Epsilon Healthcare Ltd annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31AUD -0.0512.5%
20232023-12-31AUD -0.00-93.3%
20242024-12-31AUD -0.02341.7%
20252025-12-31AUD -0.00-78.6%
Epsilon Healthcare Ltd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12019-03-31N/A
Q22019-06-30N/A
Q42019-12-31N/A
Q42020-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2019YOY CHG

Revenue

A$1.20M

+79.9%

Gross Profit

A$284.91K

+50.0%

Gross Margin

23.78%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-A$2.96M

-36.2%

EBITDA

-A$2.83M

-34.8%

Quarterly Fundamentals

Name
Q2 2019YOY CHG

Total Cash

A$6.97M

N/A

Total Debt

A$5.11M

N/A

Accounts Receivable

A$1.53M

N/A

Inventory

A$2.09M

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$3.79M

N/A

Return on Assets

-31.34%

N/A

Return on Invested Capital

-33.70%

N/A

Free Cash Flow

-A$178.67K

+76.4%

Operating Cash Flow

A$0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,718.60-0.00%
^DJIDJI
$53,414.25-0.01%
^IXICNASDAQ
$26,506.99-0.00%
BTCBitcoin
$79,182.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$104.90+0.09%
NOKNokia
$10.74+0.07%
BNCCea Industries
$5.11+0.46%
NVDANvidia
$226.38-0.02%

Questions About THC

What is the current price of Epsilon Healthcare Ltd?

Epsilon Healthcare Ltd is trading at N/A per share.

What is the 52-week range for Epsilon Healthcare Ltd?

Over the past 52 weeks, Epsilon Healthcare Ltd has traded between N/A and N/A.

How much debt does Epsilon Healthcare Ltd have?

As of the most recent reporting period, Epsilon Healthcare Ltd reported total debt of A$10.35M.

How much cash does Epsilon Healthcare Ltd have on hand?

Epsilon Healthcare Ltd reported A$242.86K in cash and cash equivalents in its most recent financial results.

What is Epsilon Healthcare Ltd’s dividend yield?

Epsilon Healthcare Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services